2nd Annual OB/GYN Women's Health Forum

Wednesday, November 13, 2024, 7:00 AM - 6:00 PM, NYAM, New York, NY


This one day menopause summit will include what is menopause, how it is diagnosed and managed. It will also include women's health across the continuum of the lifespan, and sexual health after menopause. Concurrent to hormonal and age related chances, the course will cover skin, bone, and muscle health, weight and metabolism, and patent-centered priorities around aging and longevity

1. Summarize Menopausal Health and evaluate related topics such as mental, hormonal, and sexual wellness
2. Discuss emerging medial science to construct a wholistic picture of skin, bone, and muscle health, as well as weight and metabolism, aging and longevity

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (6.00 hours), Non-Physician Attendance (6.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Wednesday, November 13, 2024